Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02697097
NCT02697097UnknownNot Applicable

Muscle Strength in Femoroacetabular Impingement: A Comparative Study of Patients With FAI Versus Normal Controls

Cambridge University Hospitals NHS Foundation Trust1 site in 1 country20 target enrollmentStarted: April 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
20
Locations
1
Primary Endpoint
Muscle Strength on Dynamometer
Study OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsSitesRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

Hip Muscle Strength in femoro-acetabular impingement participants versus normal controls.

To investigate the hip muscle strength in a normal control group and compare this to patients who have a diagnosis of femoro-acetabular impingement (diagnosed clinically and with confirmed radiological features).

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Males and Females.
  • •Control group - Normal range of movement and no evidence of femoro-acetabular impingement on clinical examination (negative impingement test, no symptoms).
  • •Participants with femoro-acetabular impingement as diagnosed clinically and on radiological imaging for the comparison group (MRI).

Exclusion Criteria

  • •Patients under the age of
  • •Patients over the age of
  • •Control group - evidence of underlying pathology affecting the hip, abnormal range of motion, evidence of femoro-acetabular impingement on clinical examination.
  • •Previous surgery of the hip joints.
  • •Medical history of arthritis (including rheumatoid and reactive).
  • •Family history of femoro-acetabular impingement (control arm participants).
  • •Patients who are currently experiencing or have experienced hip pain in the previous 1 year (control arm).
  • •Other conditions (e.g. neurological, muscular dystrophy etc) which may affect hip muscle strength.

Outcomes

Primary Outcomes

Muscle Strength on Dynamometer

Time Frame: 3 months

Secondary Outcomes

  • Kinematics of the Hip - Range of Movement(3 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Vikas Khanduja MA FRCS (Orth)

Principal Investigator

Cambridge University Hospitals NHS Foundation Trust

Study Sites (1)

Loading locations...

Similar Trials

Completed
Not Applicable
Muscular and Functional Performance in FAIS PatientsFemoroacetabular Impingement
NCT03669471Hvidovre University Hospital45
Active, not recruiting
Not Applicable
Hip Impingement - Understanding Cartilage DamageFemoroacetabular Impingement
NCT01546493Ottawa Hospital Research Institute70
Unknown
Not Applicable
Trial for Femoroacetabular Impingement TreatmentFemoroacetabular Impingement
NCT01893034University of Oxford120
Completed
Not Applicable
Femoroacetabular Impingement RandomiSed Controlled TrialFemoroacetabular Impingement
NCT01623843McMaster University220
Enrolling By Invitation
Not Applicable
Biomechanical Assessment of Femoroacetabular ImpingementFemoro Acetabular Impingement
NCT01575964University of Utah36